Vaxcyte, Inc. PCVX FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Vaxcyte, Inc.'s FX effect on cash?
- Vaxcyte, Inc. (PCVX) reported FX effect on cash of -$664K in Q1 2026.
- How has Vaxcyte, Inc.'s FX effect on cash changed year-over-year?
- Vaxcyte, Inc.'s FX effect on cash decreased by 156.7% year-over-year, from $1.17M to -$664K.
- What is the long-term trend for Vaxcyte, Inc.'s FX effect on cash?
- Over 3 years (2021 to 2025), Vaxcyte, Inc.'s FX effect on cash has grown at a 77.1% compound annual growth rate (CAGR), from -$439K to $2.44M.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.